近距离放疗施源器挡块对放疗剂量分布的影响
王新1 ,刘浩1,2 ,李公平2 ,唐成琼1 ,许敏3
新疆医科大学附属肿瘤医院,新疆
Impact of Shielding in Applicator on Dose Distribution in Brachytherapy
WANG Xin1 , LIU Hao1,2 , LI Gong-ping2 , TANG Cheng-qiong1 , XU Min3
1. Xinjiang Tumor Hospital, Xinjiang
Medical University, Urumqi Xinjiang
830011, China; 2. School of Nuclear
Science and Technology, Lanzhou
University, Gansu Lanzhou 730000,
China; 3. Urumqi Youyi Hospital,
Urumqi Xinjiang 830049, China
摘要 本文根据在近距离放疗施源器中添加挡块有利于保护正常组织的原则,使用Ir-192放射源和圆柱形施源器制定治疗计划,并在施源器内分别添加90°和180°挡块,得到计划剂量分布结果。随后借助特制的模体,采用二维电离室矩阵,分别从施源器冠状面和矢状面测量剂量分布,采用γ分析法(3%,3 mm)比较计划剂量分布和实测剂量分布差异。结果表明,挡块遮挡区内组织器官的辐射剂量远低于肿瘤的处方剂量,说明使用挡块可以有效降低辐射剂量,保护正常组织器官。
关键词 :
近距离治疗剂量分布 ,
带挡块施源器 ,
二维矩阵 ,
辐射剂量
Abstract :The paper aims to investigate principle of applying shieding application to spare healthy tissues in brachytherapy with the use of Ir-192 in designing the treatment regimen. The 90° and 180° shieldings were added to the applicator to calculate the result of dose distribution. Dose distribution was then measured using a 2D ion chamber array dosimeter in the transverse and coronal planes for these treatment plans. Gama analysis method (3%, 3 mm) was adopted to compare the dose distribution with the TPS calculations. The results indicate that the dose distribution to the organs in the shield shadow were obviously much lower than the prescribed doses for treatment volume and essentially remained within their tolerance limits for clinical dose prescriptions. It is concluded that the shielding application can effectively reduce the radiation dosage and protect normal tissues and organs.
Key words :
brachytherapy dose distribution
shielded applicator
two-dimensional matrix
radiation dose
收稿日期: 2015-08-28
基金资助: 乌鲁木齐市科技计划项目(Y12310011)
作者简介 :
current clinical practice in permanent and temporary prostate
brachytherapy: 2010 update[J].Brachytherapy,2012,11(4):299-305.
brachytherapy: 2010 update[J].Brachytherapy,2012,11(4):299-305.
[3]
Strnad V,Sauer R,Niehoff P.Evaluation of(balloon) brachytherapy
for partial breast irradiation in breast cancer based on current
meta-analyses[J].Strahlenther Onkol,2013,189(10):899-901.
13
(4):352-360.
13
(4):352-360.
影响的研究[J].中国医疗器械杂志,2013,37(4):301-303.
[5]
Uniyal SC,Sharma SD,Naithani UC.Dosimetric verification
[5]
Uniyal SC,Sharma SD,Naithani UC.Dosimetric verification
[5]
Uniyal SC,Sharma SD,Naithani UC.Dosimetric verification
of a high dose rate brachytherapy treatment planning system
of a high dose rate brachytherapy treatment planning system
of a high dose rate brachytherapy treatment planning system
in homogeneous and heterogeneous media[J].Phys Med,
in homogeneous and heterogeneous media[J].Phys Med,
影响的研究[J].中国医疗器械杂志,2013,37(4):301-303.
[1]
Miglierini P,Malhaire JP,Goasduff G,et al.Cervix cancer
[1]
Miglierini P,Malhaire JP,Goasduff G,et al.Cervix cancer
[1]
Miglierini P,Malhaire JP,Goasduff G,et al.Cervix cancer
brachytherapy: high dose rate[J].Cancer Radiother,2014,18(5-6):
brachytherapy: high dose rate[J].Cancer Radiother,2014,18(5-6):
45
2-457.
current clinical practice in permanent and temporary prostate
[3]
Strnad V,Sauer R,Niehoff P.Evaluation of(balloon) brachytherapy
for partial breast irradiation in breast cancer based on current
[4]
Yao R,Templeton AK,Liao Y,et al.Optimization for high-doserate
annealing and gradient descent[J].Brachytherapy,2014,
annealing and gradient descent[J].Brachytherapy,2014,
13
(4):352-360.
45
2-457.
[2]
Buyyounouski MK,Davis BJ,Prestidge BR,et al.A survey of
brachytherapy: 2010 update[J].Brachytherapy,2012,11(4):299-305.
for partial breast irradiation in breast cancer based on current
meta-analyses[J].Strahlenther Onkol,2013,189(10):899-901.
brachytherapy of cervical cancer with adaptive simulated
20
13,29(2):171-177.
影响的研究[J].中国医疗器械杂志,2013,37(4):301-303.
brachytherapy: high dose rate[J].Cancer Radiother,2014,18(5-6):
45
2-457.
[2]
Buyyounouski MK,Davis BJ,Prestidge BR,et al.A survey of
[2]
Buyyounouski MK,Davis BJ,Prestidge BR,et al.A survey of
current clinical practice in permanent and temporary prostate
[3]
Strnad V,Sauer R,Niehoff P.Evaluation of(balloon) brachytherapy
meta-analyses[J].Strahlenther Onkol,2013,189(10):899-901.
[4]
Yao R,Templeton AK,Liao Y,et al.Optimization for high-doserate
[4]
Yao R,Templeton AK,Liao Y,et al.Optimization for high-doserate
brachytherapy of cervical cancer with adaptive simulated
brachytherapy of cervical cancer with adaptive simulated
annealing and gradient descent[J].Brachytherapy,2014,
in homogeneous and heterogeneous media[J].Phys Med,
20
13,29(2):171-177.
20
13,29(2):171-177.
[6]
姜瑞瑶,熊霏,黄国锋.不同材质金属植入物对放疗剂量分布
[6]
姜瑞瑶,熊霏,黄国锋.不同材质金属植入物对放疗剂量分布
[6]
姜瑞瑶,熊霏,黄国锋.不同材质金属植入物对放疗剂量分布
[1]
林观生a ,马周鹏a ,付文兵a ,邓君启b . 双低剂量联合iDose4迭代重建在头颈部CTA中的应用 [J]. 中国医疗设备, 2019, 34(3): 68-71.
[2]
陈振,陈自谦,钟群,肖慧,许尚文,付丽媛,陶超超. 基于体重优化CT扫描条件对PET/CT成像的CT辐射剂量与图像质量的影响研究 [J]. 中国医疗设备, 2019, 34(2): 25-27.
[3]
袁颖1,2 ,钟朝辉2 ,吴天棋1 ,白玫1 . 自动管电流调节技术下螺距对胸部CT图像质量及辐射剂量影响的体模研究 [J]. 中国医疗设备, 2019, 34(1): 74-77.
[4]
陈进良1 ,胡洋1 ,袁华1 ,刘修法1 ,杨彬1 ,谢长军2 . 儿童胸部数字化X线摄影参数优化与成像质量探讨 [J]. 中国医疗设备, 2019, 34(1): 69-73.
[5]
钟朝辉,陈疆红,原媛,杨正汉,王振常,张婷婷,张景东. 高时间分辨率宽体探测器CT对心律失常患者冠状动脉CTA的可行性研究 [J]. 中国医疗设备, 2018, 33(6): 59-62.
[6]
智婷婷,卢铃铨,周星帆,王利伟,殷信道. 双源CT中等螺距扫描模式在主动脉血管造影中的应用研究 [J]. 中国医疗设备, 2018, 33(5): 63-66.
[7]
杨文兵,查云飞,阳朝晖,谢宝君,邢栋,杨仁杰. 冠状动脉追踪冻结技术降低前瞻性心电门控CTA成像辐射剂量的方法研究 [J]. 中国医疗设备, 2018, 33(4): 69-73.
[8]
袁颖a ,卢东生b ,钟朝辉a . 管电压对胸部CT图像质量及辐射剂量的影响 [J]. 中国医疗设备, 2018, 33(2): 69-72.
[9]
原媛,钟朝辉,王振常,张婷婷,张景东. 冠脉CTA自由呼吸扫描与屏息扫描的辐射剂量对比研究 [J]. 中国医疗设备, 2018, 33(10): 74-78.
[10]
严昂1 ,易大志2 ,黄辉1 ,邹庆辉1 . 移动DR辐射剂量的计算、验证及改进 [J]. 中国医疗设备, 2018, 33(1): 78-81.
[11]
钟朝辉,陈疆红,原媛,王振常,张婷婷,张景东. 冠状动脉CTA扫描中采用智能期相技术与手动选取最佳期相的一致性 [J]. 中国医疗设备, 2017, 32(9): 63-66.
[12]
李剑,石磊,刘豹,王栋,
杨红兵,刘从伟,吴志斌,
石明国. 低辐射剂量和低对比剂用量在门静脉血管成像技术的应用 [J]. 中国医疗设备, 2017, 32(5): 11-14.
[13]
钟承双,徐谢生. PET/CT不同管电压下的CT加权剂量指数测量及其对图像质量的影响 [J]. 中国医疗设备, 2017, 32(5): 105-107.
[14]
周泽旺,张昌政,郑瑛琪,
李丹丹. 能谱CT单能量成像结合低浓度对比剂在门静脉成像的应用价值 [J]. 中国医疗设备, 2017, 32(5): 87-90.
[15]
肖太星. 多层螺旋CT“双低”扫描在冠状动脉成像中的临床应用 [J]. 中国医疗设备, 2017, 32(3): 52-57.